Philip Morris (PM) AI Stock Analysis

• Market Cap: $272.08B
• Dividend Yield: 3.59%
• Average Volume (3M): 5.48M
• Price to Earnings (P/E): 21.0
• Beta (1Y): -0.08
• Revenue Growth: 7.72%
• EPS Growth: -12.45%
• Country: US
• Employees: 83,100
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Tobacco
• EPS (TTM): 1.70
• Shares Outstanding: 1,556,679,600
• 10 Day Avg. Volume: 5,894,845
• 30 Day Avg. Volume: 5,483,885
• PEG Ratio: 0.36
• Price to Book (P/B): -24.97
• Price to Sales (P/S): 6.14
• P/FCF Ratio: 23.40
• Enterprise Value/Market Cap: 1.15
• Enterprise Value/Revenue: 7.70
• Enterprise Value/Gross Profit: 11.47
• Enterprise Value/Ebitda: 17.92
• 1Y Price Target: $197.86
• Price Target Upside: 13.21% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 11
• EPS Forecast (FY): 8.45
• Revenue Forecast (FY): $43.75B

• Rating: 69 Neutral
• Price Target: $191.00 ▲(9.28% Upside)
• Action: Downgraded Date: 03/14/26
• Date: Action: Downgraded 03/14/26

The score is driven mainly by strong profitability and cash generation plus upbeat guidance tied to smoke-free growth, partially offset by elevated balance-sheet risk (negative equity and high debt). Technical signals are currently weak, while valuation is supported by the dividend but not especially cheap on earnings.

Positive Factors

High and Sustainable Margins

Philip Morris reports structurally high gross and operating margins (gross >67%, adjusted operating margin ~40%), reflecting strong pricing power, mix shift to higher‑margin smoke‑free products and disciplined cost programs. These persistent margins underpin cash generation and fund reinvestment and dividends over the medium term.

Robust Cash Generation

Consistent, large operating and free cash flows (roughly $9–12bn historically, $12.2bn in 2025 and guidance to ~€13.5bn) provide durable funding for capex, buybacks, the dividend and deleveraging. Reliable cash conversion supports strategic investments in smoke‑free growth while absorbing cyclical shocks.

Scale and Momentum in Smoke‑Free

Smoke‑free products account for ~42% of revenue (~$17bn) with accelerating IQOS and pouch volumes, reflecting structural portfolio transition. Scale across 106 markets and expanding legal‑age user base make smoke‑free the company’s durable growth engine, offsetting combustible declines and supporting higher long‑run margins.

Negative Factors

Weak Balance Sheet / Negative Equity

Persistent negative shareholder equity and sizable, rising debt levels limit financial flexibility. Negative equity elevates refinancing and covenant risk, constrains balance‑sheet responses to shocks and makes leverage metrics and capital returns more sensitive to earnings volatility even as management targets gradual deleveraging.

Excise and Regulatory Tax Risks

Planned excise hikes in Japan and large regional tax moves (e.g., India, Mexico) create structural volume and pricing headwinds for heated‑tobacco and combustibles. These policy shifts can persistently slow category adoption or force higher prices, pressuring volumes, mix and the pace of smoke‑free migration in key markets.

Execution & Regulatory Risk for Pouches (ZYN)

U.S. pouch growth is exposed to supply, inventory normalization and regulatory timing (pending FDA submissions). Channel inventory build and supply constraints can compress near‑term offtake and margin realization, while regulatory delays or adverse rulings would slow a key growth vector and raise execution risk.

Philip Morris Business Overview & Revenue Model

Company Description

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

How the Company Makes Money

Philip Morris generates revenue primarily through the sale of its tobacco products, which include both traditional cigarettes and smoke-free alternatives like heated tobacco products and e-vapor products. The company's key revenue streams come from the global sale of these products, with a significant portion of earnings derived from its flagship brand, Marlboro. Additionally, Philip Morris has been investing heavily in research and development to innovate and expand its portfolio of reduced-risk products, which are increasingly becoming a focus as regulatory pressures on smoking increase. The company engages in significant marketing and distribution partnerships to enhance product reach and consumer engagement, contributing to overall sales. The ongoing transition towards smoke-free products is expected to play a crucial role in the company’s future revenue growth.

Philip Morris Financial Statement Overview

Summary

Operations are strong (high and consistent gross/EBIT margins and robust, improving free cash flow), but the balance sheet is a major offset with persistently negative shareholder equity and sizeable debt, increasing financial risk despite earnings power.

Income Statement

Profitability is a clear strength: gross margin stayed high (~63%–68%) and operating profitability remained very strong (EBIT margin ~34%–41%) across 2020–2025. After a modest 2024 net margin (~19%), 2025 rebounded to a strong ~28% with net income rising meaningfully. Revenue growth has been positive in most years (brief dip in 2020), but the pace is uneven and the 2025 growth figure appears unusually high versus the underlying revenue trend, suggesting a less stable growth trajectory than the margin profile.

Balance Sheet

Leverage and capital structure are the key weak spots. Total debt is large and has generally trended higher since 2020, while shareholder equity is negative in every year shown (roughly -$9B to -$13B), which limits balance-sheet flexibility and makes equity-based leverage and return measures unfavorable. Asset growth is moderate, but the persistent negative equity profile elevates financial risk despite strong earnings power.

Cash Flow

Cash generation is consistently strong and supportive. Operating cash flow is healthy (roughly $9B–$12B annually) and free cash flow is robust, improving sharply in 2025 (with strong free-cash-flow growth). Cash conversion is solid, with free cash flow generally covering most of net income and reaching full coverage in 2025. The main watch-out is volatility in year-to-year free-cash-flow growth (declines in 2022–2023 before re-accelerating).

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	40.65B	37.88B	35.17B	31.76B	31.41B
Gross Profit	27.28B	24.55B	22.28B	20.36B	21.38B
EBITDA	17.46B	15.75B	13.37B	13.48B	13.97B
Net Income	11.35B	7.03B	7.79B	9.05B	9.11B
Balance Sheet
Total Assets	69.19B	61.78B	65.30B	61.68B	41.29B
Cash, Cash Equivalents and Short-Term Investments	4.87B	4.22B	3.06B	3.21B	4.50B
Total Debt	48.84B	45.70B	47.91B	43.12B	27.81B
Total Liabilities	77.21B	71.65B	74.75B	67.99B	49.50B
Stockholders Equity	-9.99B	-11.75B	-11.22B	-8.96B	-10.11B
Cash Flow
Free Cash Flow	10.66B	10.77B	7.88B	9.73B	11.22B
Operating Cash Flow	12.23B	12.22B	9.20B	10.80B	11.97B
Investing Cash Flow	-4.49B	-1.09B	-3.60B	-15.68B	-2.36B
Financing Cash Flow	-7.61B	-9.48B	-5.58B	3.81B	-11.98B

Philip Morris Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 174.78
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PM, the sentiment is Positive. The current price of 174.78 is below the 20-day moving average (MA) of 179.32, below the 50-day MA of 175.71, and above the 200-day MA of 165.45, indicating a neutral trend. The MACD of -1.69 indicates Positive momentum. The RSI at 46.92 is Neutral, neither overbought nor oversold. The STOCH value of 54.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PM.

Philip Morris Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RLX	76 Outperform	$2.78B	22.23	5.73%	0.35%	51.49%	21.43%
PM	69 Neutral	$272.08B	20.98	-105.12%	3.59%	7.72%	-12.45%
BTI	69 Neutral	$131.87B	11.84	16.33%	5.22%	0.48%	―
MO	66 Neutral	$112.90B	13.92	-215.18%	7.02%	-0.96%	-11.42%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
TPB	59 Neutral	$1.77B	34.13	20.84%	0.28%	6.71%	8.16%
UVV	56 Neutral	$1.32B	9.94	5.81%	6.15%	3.01%	-7.14%

Philip Morris Corporate Events

Philip Morris unveils new segment structure and metrics

Philip Morris International Inc. has reorganized its operations into two main business units, International and U.S., and from January 1, 2026 replaced its four geographic segments with three reportable segments: International Smoke-Free, International Combustibles and U.S., which includes its Aspeya wellness business. The company said on March 13, 2026 that it had published unaudited recast shipment volume and financial data aligned with the new structure, introduced a new profitability metric, Operating Companies Income, and reclassified certain corporate expenses, while stressing that the changes do not alter previously reported consolidated results but aim to give investors clearer insight into performance under its evolving smoke-free strategy.

The new segment structure and OCI measure are intended to improve transparency around the performance of PMI’s smoke-free and U.S. businesses, reflecting the growing scale of reduced-risk products and the strategic importance of the U.S. market. By keeping consolidated historical results unchanged and framing the recast figures as supplemental, PMI is signaling that the move is about analytical clarity and internal alignment rather than revising its financial history, a shift that could help investors better track the company’s transition away from traditional combustibles.

The most recent analyst rating on (PM) stock is a Hold with a $192.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Philip Morris Declares Quarterly Dividend Amid Smoke-Free Shift

On March 5, 2026, Philip Morris International Inc. announced that its board declared a regular quarterly dividend of $1.47 per common share, underscoring the group’s continued commitment to returning cash to shareholders. The dividend will be payable on April 13, 2026, to investors of record as of March 19, 2026, with the same date set as the ex-dividend date.

The move comes as Philip Morris advances its transition toward smoke-free products, which already account for a substantial share of its revenues and user base. Sustaining a robust dividend alongside heavy investment in reduced-risk and non-nicotine offerings highlights the company’s effort to balance shareholder returns with long-term portfolio transformation in the global nicotine and wellness markets.

The most recent analyst rating on (PM) stock is a Buy with a $210.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Philip Morris Highlights Momentum in Smoke-Free Revenue Shift

On February 18, 2026, Philip Morris International used its appearance at the Consumer Analyst Group of New York Conference to showcase the scale and momentum of its transition toward smoke-free products, highlighting that annual smoke-free net revenues have reached about $17 billion across 106 markets and now account for roughly 42% of total net revenues. Management emphasized that several regions, especially Europe, are already majority smoke-free by net revenues, that overall shipment volumes have shifted from structural decline to low single-digit growth driven by smoke-free products, and that the wider cigarette industry outside China and the U.S. shows steeper declines in markets where smoke-free products are available, underscoring both PMI’s strategic repositioning and the growing regulatory and public-health acceptance of tobacco harm-reduction models centered on non-combustible nicotine options.

The most recent analyst rating on (PM) stock is a Buy with a $210.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Philip Morris Reaffirms 2026 EPS Outlook and Growth

On February 18, 2026, Philip Morris International said its CEO Jacek Olczak and CFO Emmanuel Babeau would present at the Consumer Analyst Group of New York Conference, outlining how the transformed group is navigating an evolving operating environment and scaling its smoke-free brands. The company also highlighted its focus on shareholder value, including 2026–2028 growth targets, underlining its strategic push to consolidate leadership in next-generation nicotine products.

At the event, PMI reaffirmed its 2026 full-year reported diluted EPS forecast of $7.87 to $8.02 announced on February 6, with adjusted diluted EPS seen between $8.38 and $8.53, implying 11.1% to 13.1% growth versus $7.54 in 2025. Excluding a favorable $0.27 currency impact per share, the company projects adjusted EPS growth of 7.5% to 9.5%, signaling confidence in its earnings trajectory despite ongoing regulatory, litigation and macroeconomic risks flagged in its cautionary statements.

The most recent analyst rating on (PM) stock is a Buy with a $210.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Philip Morris boosts U.S. smoke-free investments and jobs

On January 15, 2026, Philip Morris International and its U.S. businesses disclosed that since 2022 they have deployed more than $20 billion in U.S.-related investments, largely tied to the 2022 acquisition of Swedish Match and subsequent spending on domestic manufacturing, commercial rights, infrastructure and jobs, including more than $1 billion invested after the acquisition through September 30, 2025. The company highlighted new infrastructure projects in Colorado, Kentucky and North Carolina expected to create over 1,000 direct and 1,500 indirect jobs and deliver an estimated annual economic impact exceeding $800 million, alongside more than $35 million in charitable contributions since 2022—nearly $12 million of which went to about 600 nonprofits in 47 states and Washington, D.C. in 2025 alone. PMI U.S. underscored its role as a U.S. leader in “modern nicotine” and smoke-free products such as ZYN and IQOS, noting that PMI affiliates hold a dominant share of FDA modified-risk and premarket tobacco product marketing authorizations, and that its U.S. workforce has grown from several hundred to over 3,000 employees as it seeks to accelerate the shift of America’s roughly 30 million adult smokers to science-based, smoke-free alternatives.

The most recent analyst rating on (PM) stock is a Buy with a $185.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.